ABP-671

· Atom Therapeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ABP-671, covering 2023-04-12 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia [Phase 2]